Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00729495 · ClinicalTrials.gov registry record · Phase 1
Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib
A Phase 1 study of Healthy Volunteer, sponsored by POZEN.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT00729495 is a Phase 1 study of Healthy Volunteer that has completed, run by POZEN. The registered enrollment target is 80 participants, below the 201-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00729495, a Phase 1 study of Healthy Volunteer, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Phase I study designed to test the hypothesis that overencapsulated celecoxib 200 mg qd is bioequivalent to commercial celecoxib 200 mg qd. Approximately 90 healthy volunteers will be randomized to yield approximately 80 completers. The study is an open label, randomized, 2-way crossover with single dosing followed by a 7-day washout period between treatment arms
Conditions Studied
Interventions
- DRUG celecoxib
Study Locations (1)
Missouri
- Research - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-07 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00729495
The ClinicalTrials.gov registry entry for NCT00729495 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 112 other Healthy Volunteer trials with a reported enrollment target (60% lower). The listed sponsor is POZEN, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteer appearing as the primary indexed condition, and to 1 intervention - of which celecoxib is the first listed.
NCT00729495 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT00729495 about?
NCT00729495 is a clinical study titled "Phase I Study to Evaluate Bioavailability of Overencapsulated Celecoxib". Phase I study designed to test the hypothesis that overencapsulated celecoxib 200 mg qd is bioequivalent to commercial celecoxib 200 mg qd. Approximately 90 healthy volunteers will be randomized to yield approximately 80 completers. The study is an open label, randomized, 2-way crossover with single...
What is the current status of trial NCT00729495?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2008-07. Estimated completion is 2008-10.
What conditions does trial NCT00729495 study?
This clinical trial studies the following conditions: Healthy Volunteer.
What interventions are being tested in trial NCT00729495?
The interventions under investigation include: celecoxib (DRUG).
Who is sponsoring clinical trial NCT00729495?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00729495 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Healthy Volunteer Study
RECRUITING · Phase 1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
RECRUITING · Phase 1
-
A First-in-Human Single and Multiple Ascending Dose Study of MT-201
RECRUITING · Phase 1
-
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
RECRUITING · Phase 1
-
A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian Participants
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.